RAS-association domain family 1A regulates the abnormal cell proliferation in psoriasis via inhibition of

Jinjing Jia1,2,3, Ning Wang4, Yan Zheng4

  • 1State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.

Insights

RAS-association domain family 1A (RASSF1A) may treat psoriasis by reducing Yes-associated protein (YAP) levels. Inhibiting RASSF1A methylation or boosting its expression could offer new psoriasis therapies.

Area of Science:

  • Dermatology
  • Molecular Biology
  • Oncology

Background:

  • Psoriasis is a chronic inflammatory skin condition with unknown causes.
  • RAS-association domain family 1A (RASSF1A) is an upstream negative regulator.
  • Yes-associated protein (YAP) is a key factor in cell growth and proliferation.

Purpose of the Study:

  • To investigate the role of RASSF1A in psoriasis pathogenesis.
  • To analyze the effect of RASSF1A on YAP in psoriasis.
  • To explore potential therapeutic strategies targeting RASSF1A methylation and expression.

Main Methods:

  • Analyzed RASSF1A expression and methylation in psoriatic skin lesions from patients and a mouse model.
  • Utilized a human keratinocyte cell model and an imiquimod-induced mouse model of psoriasis.
  • Administered a methylation inhibitor (5-Aza-CdR) and RASSF1A-overexpressing lentivirus to assess effects on RASSF1A/YAP signaling and disease markers.

Main Results:

  • Increased RASSF1A methylation correlated with decreased RASSF1A expression in psoriasis.
  • RASSF1A upregulation (via demethylation or lentivirus) reduced YAP expression.
  • Interventions improved skin lesions, reduced keratinocyte proliferation, induced G0/G1 cell cycle arrest, and decreased inflammation (cytokines, ERK, STAT3, NF-κB pathways).

Conclusions:

  • RASSF1A inhibits YAP expression, suggesting a therapeutic role in psoriasis.
  • Targeting RASSF1A methylation or expression may be a viable strategy for psoriasis treatment.
  • Further research into RASSF1A-targeted therapies could benefit psoriasis patients.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.9K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.1K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.7K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
6.1K